Past voting member and Chair of US FDA Oncology Drug Advisory Committee (ODAC) Deputy Director of Mayo Clinic Comprehensive Cancer Center for Clinical Research Internationally renowned authority on the regulatory approval of drugs for hematologic malignancies and clinical trials
Dr. Mould is a Member with more than 30 years of experience in the pharmaceutical industry, specializing in population pharmacokinetic and pharmacodynamic modeling. She has extensive expertise in preparing and supporting regulatory submissions to the FDA and has contributed to numerous applications involving hematopoietic agents, monoclonal antibodies, and anti-cancer therapies. Her deep scientific and regulatory knowledge […]
Dr. Maitland is an internationally recognized authority in early-phase clinical trial design, pharmacokinetics, Project Optimus, and regulatory strategy. He currently serves as Vice President for Clinical Development at Pathos and previously served as Medical Lead for CRISPR technologies at Intellia Therapeutics. A respected physician-scientist and member of the ASCO Cancer Research Committee, Dr. Maitland brings extensive expertise […]
Dr. Burris serves as President and Chief Medical Officer of the Sarah Cannon Research Institute, where he also leads drug development efforts as Executive Director. An internationally recognized authority in drug development, clinical trials, and the regulatory process, he has played a leading role in advancing innovative cancer therapies and shaping clinical research strategy. Skip also […]
Dr. Pecora is internationally recognized as an authority in stem cell transplantation. He is the founder of the John Theurer Cancer Center in Hackensack, New Jersey, and has spent more than 25 years building biotechnology companies focused on advancing innovative immunotherapies for the treatment of cancer. Dr. Pecora’s leadership spans clinical care, translational research, and […]
Dr. Loughran serves as Director of Nanovations and is the Director of the UVA Comprehensive Cancer Center, an NCI-designated cancer center. Internationally recognized as a renowned cancer biologist, Dr. Loughran is also the most significantly funded research scientist in the history of the Commonwealth of Virginia. His groundbreaking contributions to cancer research and translational medicine have […]